EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis

Authors

Keywords

EFHD2, Recurrence, Adjuvant chemotherapy, NOX4, ABCC1, Ibuprofen

Journal

Volume 34, Issue -, Pages 101571

Publisher

Elsevier BV

Online

2020-05-16

DOI

10.1016/j.redox.2020.101571

Contact the author

Explore over 38,000 international journals covering a vast array of academic fields.

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started